Evaluation of the Impact of a Chronic Total Coronary Occlusion on Ventricular Arrhythmias and Long‐Term Mortality in Patients With Ischemic Cardiomyopathy and an Implantable Cardioverter‐Defibrillator (the <styled-content style="fixed-case">eCTO</styled-content>py‐in‐<styled-content style="fixed-case">ICD</styled-content> Study)

BackgroundPrevious studies report conflicting results about a higher incidence of ventricular arrhythmias in patients with a chronic total coronary occlusion (CTO). We aimed to investigate this association in a large cohort of implantable cardioverter defibrillator patients with long‐term follow‐up....

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ivo M. van Dongen, Dilek Yilmaz, Joëlle Elias, Bimmer E. P. M. Claessen, Ronak Delewi, Reinoud E. Knops, Arthur A. M. Wilde, Lieselot van Erven, Martin J. Schalij, José P. S. Henriques
Formato: article
Lenguaje:EN
Publicado: Wiley 2018
Materias:
Acceso en línea:https://doaj.org/article/767b16fbb76a4230b50171d574107ba4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:767b16fbb76a4230b50171d574107ba4
record_format dspace
spelling oai:doaj.org-article:767b16fbb76a4230b50171d574107ba42021-11-12T17:01:48ZEvaluation of the Impact of a Chronic Total Coronary Occlusion on Ventricular Arrhythmias and Long‐Term Mortality in Patients With Ischemic Cardiomyopathy and an Implantable Cardioverter‐Defibrillator (the <styled-content style="fixed-case">eCTO</styled-content>py‐in‐<styled-content style="fixed-case">ICD</styled-content> Study)10.1161/JAHA.118.0086092047-9980https://doaj.org/article/767b16fbb76a4230b50171d574107ba42018-05-01T00:00:00Zhttps://www.ahajournals.org/doi/10.1161/JAHA.118.008609https://doaj.org/toc/2047-9980BackgroundPrevious studies report conflicting results about a higher incidence of ventricular arrhythmias in patients with a chronic total coronary occlusion (CTO). We aimed to investigate this association in a large cohort of implantable cardioverter defibrillator patients with long‐term follow‐up. Methods and ResultsAll consecutive patients from 1992 onwards who underwent implantable cardioverter defibrillator implantation for ischemic cardiomyopathy at the Leiden University Medical Center were evaluated. Coronary angiograms were reviewed for the presence of a CTO. The occurrence of ventricular arrhythmias and survival status at follow‐up were compared between patients with and patients without a CTO. A total of 722 patients constitute the study cohort (age 66±11 years; 84% males; 74% primary prevention, median left ventricular ejection fraction 30% [first–third quartile: 25–37], 44% received a cardiac resynchronization therapy defibrillator). At baseline, 240 patients (33%) had a CTO, and the CTOs were present for at least 44 (2–127) months. The median follow‐up duration was 4 (2–6) years. On long‐term follow‐up, CTO patients had a higher crude appropriate device therapy rate (37% versus 27%, P=0.010) and a lower crude survival rate (51% versus 67%, P<0.001) compared with patients without a CTO. Corrected for baseline characteristics including left ventricular ejection fraction, the presence of a CTO was an independent predictor for appropriate device therapy. ConclusionsThe presence of a CTO in implantable cardioverter defibrillator patients was associated with more appropriate device therapy and worse prognosis at long‐term follow‐up. Further investigation is warranted regarding a potential beneficial effect of CTO revascularization on the incidence of ventricular arrhythmias.Ivo M. van DongenDilek YilmazJoëlle EliasBimmer E. P. M. ClaessenRonak DelewiReinoud E. KnopsArthur A. M. WildeLieselot van ErvenMartin J. SchalijJosé P. S. HenriquesWileyarticlechronic total coronary occlusionimplantable cardioverter‐defibrillatorischemic cardiomyopathymortalityventricular arrhythmiaDiseases of the circulatory (Cardiovascular) systemRC666-701ENJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 10 (2018)
institution DOAJ
collection DOAJ
language EN
topic chronic total coronary occlusion
implantable cardioverter‐defibrillator
ischemic cardiomyopathy
mortality
ventricular arrhythmia
Diseases of the circulatory (Cardiovascular) system
RC666-701
spellingShingle chronic total coronary occlusion
implantable cardioverter‐defibrillator
ischemic cardiomyopathy
mortality
ventricular arrhythmia
Diseases of the circulatory (Cardiovascular) system
RC666-701
Ivo M. van Dongen
Dilek Yilmaz
Joëlle Elias
Bimmer E. P. M. Claessen
Ronak Delewi
Reinoud E. Knops
Arthur A. M. Wilde
Lieselot van Erven
Martin J. Schalij
José P. S. Henriques
Evaluation of the Impact of a Chronic Total Coronary Occlusion on Ventricular Arrhythmias and Long‐Term Mortality in Patients With Ischemic Cardiomyopathy and an Implantable Cardioverter‐Defibrillator (the <styled-content style="fixed-case">eCTO</styled-content>py‐in‐<styled-content style="fixed-case">ICD</styled-content> Study)
description BackgroundPrevious studies report conflicting results about a higher incidence of ventricular arrhythmias in patients with a chronic total coronary occlusion (CTO). We aimed to investigate this association in a large cohort of implantable cardioverter defibrillator patients with long‐term follow‐up. Methods and ResultsAll consecutive patients from 1992 onwards who underwent implantable cardioverter defibrillator implantation for ischemic cardiomyopathy at the Leiden University Medical Center were evaluated. Coronary angiograms were reviewed for the presence of a CTO. The occurrence of ventricular arrhythmias and survival status at follow‐up were compared between patients with and patients without a CTO. A total of 722 patients constitute the study cohort (age 66±11 years; 84% males; 74% primary prevention, median left ventricular ejection fraction 30% [first–third quartile: 25–37], 44% received a cardiac resynchronization therapy defibrillator). At baseline, 240 patients (33%) had a CTO, and the CTOs were present for at least 44 (2–127) months. The median follow‐up duration was 4 (2–6) years. On long‐term follow‐up, CTO patients had a higher crude appropriate device therapy rate (37% versus 27%, P=0.010) and a lower crude survival rate (51% versus 67%, P<0.001) compared with patients without a CTO. Corrected for baseline characteristics including left ventricular ejection fraction, the presence of a CTO was an independent predictor for appropriate device therapy. ConclusionsThe presence of a CTO in implantable cardioverter defibrillator patients was associated with more appropriate device therapy and worse prognosis at long‐term follow‐up. Further investigation is warranted regarding a potential beneficial effect of CTO revascularization on the incidence of ventricular arrhythmias.
format article
author Ivo M. van Dongen
Dilek Yilmaz
Joëlle Elias
Bimmer E. P. M. Claessen
Ronak Delewi
Reinoud E. Knops
Arthur A. M. Wilde
Lieselot van Erven
Martin J. Schalij
José P. S. Henriques
author_facet Ivo M. van Dongen
Dilek Yilmaz
Joëlle Elias
Bimmer E. P. M. Claessen
Ronak Delewi
Reinoud E. Knops
Arthur A. M. Wilde
Lieselot van Erven
Martin J. Schalij
José P. S. Henriques
author_sort Ivo M. van Dongen
title Evaluation of the Impact of a Chronic Total Coronary Occlusion on Ventricular Arrhythmias and Long‐Term Mortality in Patients With Ischemic Cardiomyopathy and an Implantable Cardioverter‐Defibrillator (the <styled-content style="fixed-case">eCTO</styled-content>py‐in‐<styled-content style="fixed-case">ICD</styled-content> Study)
title_short Evaluation of the Impact of a Chronic Total Coronary Occlusion on Ventricular Arrhythmias and Long‐Term Mortality in Patients With Ischemic Cardiomyopathy and an Implantable Cardioverter‐Defibrillator (the <styled-content style="fixed-case">eCTO</styled-content>py‐in‐<styled-content style="fixed-case">ICD</styled-content> Study)
title_full Evaluation of the Impact of a Chronic Total Coronary Occlusion on Ventricular Arrhythmias and Long‐Term Mortality in Patients With Ischemic Cardiomyopathy and an Implantable Cardioverter‐Defibrillator (the <styled-content style="fixed-case">eCTO</styled-content>py‐in‐<styled-content style="fixed-case">ICD</styled-content> Study)
title_fullStr Evaluation of the Impact of a Chronic Total Coronary Occlusion on Ventricular Arrhythmias and Long‐Term Mortality in Patients With Ischemic Cardiomyopathy and an Implantable Cardioverter‐Defibrillator (the <styled-content style="fixed-case">eCTO</styled-content>py‐in‐<styled-content style="fixed-case">ICD</styled-content> Study)
title_full_unstemmed Evaluation of the Impact of a Chronic Total Coronary Occlusion on Ventricular Arrhythmias and Long‐Term Mortality in Patients With Ischemic Cardiomyopathy and an Implantable Cardioverter‐Defibrillator (the <styled-content style="fixed-case">eCTO</styled-content>py‐in‐<styled-content style="fixed-case">ICD</styled-content> Study)
title_sort evaluation of the impact of a chronic total coronary occlusion on ventricular arrhythmias and long‐term mortality in patients with ischemic cardiomyopathy and an implantable cardioverter‐defibrillator (the <styled-content style="fixed-case">ecto</styled-content>py‐in‐<styled-content style="fixed-case">icd</styled-content> study)
publisher Wiley
publishDate 2018
url https://doaj.org/article/767b16fbb76a4230b50171d574107ba4
work_keys_str_mv AT ivomvandongen evaluationoftheimpactofachronictotalcoronaryocclusiononventriculararrhythmiasandlongtermmortalityinpatientswithischemiccardiomyopathyandanimplantablecardioverterdefibrillatorthestyledcontentstylefixedcaseectostyledcontentpyinstyledcontentstylefixedcaseicd
AT dilekyilmaz evaluationoftheimpactofachronictotalcoronaryocclusiononventriculararrhythmiasandlongtermmortalityinpatientswithischemiccardiomyopathyandanimplantablecardioverterdefibrillatorthestyledcontentstylefixedcaseectostyledcontentpyinstyledcontentstylefixedcaseicd
AT joelleelias evaluationoftheimpactofachronictotalcoronaryocclusiononventriculararrhythmiasandlongtermmortalityinpatientswithischemiccardiomyopathyandanimplantablecardioverterdefibrillatorthestyledcontentstylefixedcaseectostyledcontentpyinstyledcontentstylefixedcaseicd
AT bimmerepmclaessen evaluationoftheimpactofachronictotalcoronaryocclusiononventriculararrhythmiasandlongtermmortalityinpatientswithischemiccardiomyopathyandanimplantablecardioverterdefibrillatorthestyledcontentstylefixedcaseectostyledcontentpyinstyledcontentstylefixedcaseicd
AT ronakdelewi evaluationoftheimpactofachronictotalcoronaryocclusiononventriculararrhythmiasandlongtermmortalityinpatientswithischemiccardiomyopathyandanimplantablecardioverterdefibrillatorthestyledcontentstylefixedcaseectostyledcontentpyinstyledcontentstylefixedcaseicd
AT reinoudeknops evaluationoftheimpactofachronictotalcoronaryocclusiononventriculararrhythmiasandlongtermmortalityinpatientswithischemiccardiomyopathyandanimplantablecardioverterdefibrillatorthestyledcontentstylefixedcaseectostyledcontentpyinstyledcontentstylefixedcaseicd
AT arthuramwilde evaluationoftheimpactofachronictotalcoronaryocclusiononventriculararrhythmiasandlongtermmortalityinpatientswithischemiccardiomyopathyandanimplantablecardioverterdefibrillatorthestyledcontentstylefixedcaseectostyledcontentpyinstyledcontentstylefixedcaseicd
AT lieselotvanerven evaluationoftheimpactofachronictotalcoronaryocclusiononventriculararrhythmiasandlongtermmortalityinpatientswithischemiccardiomyopathyandanimplantablecardioverterdefibrillatorthestyledcontentstylefixedcaseectostyledcontentpyinstyledcontentstylefixedcaseicd
AT martinjschalij evaluationoftheimpactofachronictotalcoronaryocclusiononventriculararrhythmiasandlongtermmortalityinpatientswithischemiccardiomyopathyandanimplantablecardioverterdefibrillatorthestyledcontentstylefixedcaseectostyledcontentpyinstyledcontentstylefixedcaseicd
AT josepshenriques evaluationoftheimpactofachronictotalcoronaryocclusiononventriculararrhythmiasandlongtermmortalityinpatientswithischemiccardiomyopathyandanimplantablecardioverterdefibrillatorthestyledcontentstylefixedcaseectostyledcontentpyinstyledcontentstylefixedcaseicd
_version_ 1718430376812085248